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Abstract 
Osteoporosis is a major public health concern with millions of Americans being affected. This painful and 
oftentimes crippling disease is multifactorial in nature. Therefore, the development of osteoporosis is 
related to more issues than a person’s intake of calcium. As a result, osteoporosis is not age or gender 
dependent. Risk factors for osteoporosis include proper nutrition including calcium intake, heredity, age, 
gender, physical inactivity, smoking, excessive alcohol use, and the use of several medications. With such 
a variety of risk factors, everyone should assume risk for disease development and thus take steps for the 
prevention of this bone fragility disease. 
 
© 2004 Californian Journal of Health Promotion.  All rights reserved. 
Keywords: osteoporosis, women’s health, health education, calcium intake 
 
 
Osteoporosis is a major public health concern in 
the United States. An estimated 28 million 
Americans are already afflicted with this disease 
and approximately 1.5 million new fractures 
occur each year (Barefield, 1996; Boughton, 
1999; Krall & Dawson-Hughes, 1999; National 
Institutes of Health (NIH), 2000).  In addition to 
those already afflicted, another 18 million 
Americans have low bone density, placing them 
at risk for this disorder (NIH, 2000).   
 
Osteoporosis is a painful, sometimes crippling 
disease.  The incidence of osteoporosis has 
reached epidemic levels in the United States and 
is responsible for considerable death, illness, 
loss of independence, decreased quality of life, 
and associated economic costs (Gerrior, Putnam, 
& Bente, 1998; National Osteoporosis 
Foundation [NOF], 1998).  Estimates for the 
United States indicate that 13-18% of women 
over the age of 50 are afflicted with 
osteoporosis.  Even more startling is the estimate 
that another 37-50% of women over 50 have 
some degree of osteopenia or low bone density 
(Barefield, 1996; Gerrior, et al., 1998).   
 
Fractures that are a result of bone fragility 
account for extensive morbidity, mortality, and 
loss of function (Lappe, 1994; Turner, Taylor, & 
Hunt, 1998; Ullom-Minnich, 1999). The 
financial costs associated with osteoporotic 
fractures include direct medical charges, 
rehabilitation, and extended treatment facilities.  
Osteoporosis-related hip fractures alone result in 
estimated costs of $12.8 billion to $17.8 billion 
per year.  Rehabilitation and institutionalization 
account for approximately 40% of these costs 
while less than 1 percent is due to lost 
productivity (Barefield, 1996).  Rehabilitation 
and institutionalization costs are the largest 
majority since almost half of the individuals 
hospitalized with osteoporosis-related hip 
fractures never fully recover.  Twenty-five 
percent of the total hip fractures result in the 
person being severely handicapped.  Another 
20% of these people die within one year of a hip 
fracture (Barefield, 1996; Lappe, 1994).  As the 
population subgroup of Americans over the age 
of 65 grows, estimates indicate osteoporosis-
related costs will be greater than $62 billion by 
2020 and $200 billion by the year 2040 
(Barefield, 1996; Cummings, Rubin, & Black, 
1990). 
 
Osteoporosis is a complex multifactorial 
condition characterized by low bone mass and 
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deterioration of bone tissue, with a consequent 
increase in bone fragility and susceptibility to 
fracture (Notelovitz, 1993; Siddiqui, Shetty, & 
Duthie, 1999).  Osteoporosis is often referred to 
as the silent thief because osteoporotic bone loss 
takes place gradually throughout the course of 
many years without any signs or symptoms 
(Boughton, 1999).  This reduction in bone 
mineral density (BMD) later manifests itself as 
low-trauma fractures.  
 
To better understand osteoporosis, it is helpful to 
understand the process of bone formation.  Bone 
is living tissue that is constantly being renewed 
in a two-stage process of formation and 
resorption that occurs throughout life 
(Boughton, 1999).  During different life stages, 
the balance of these processes may weigh 
heavier in one direction than the other.  For 
example, during adolescence, bone formation 
occurs at a greater rate than bone resorption.  
The formation stage is characterized by the 
building of new bone to replace old bone by 
cells called osteoblasts.  The resorption phase is 
characterized by a higher level of bone 
breakdown than formation as a result of cells 
called osteoclasts (Boughton, 1999; Smith, 
1993). 
 
There are two main type of bone that are 
recognized: trabecular or spongy bone (25%) 
and cortical or compact bone (75%) (Smith, 
1993).  Trabecular bone forms the internal 
support system of the bone and is metabolically 
more active than cortical bone (by about ten 
times) (Notelovitz, 1993; Smith, 1993; 
Wardlaw, 1993).  Cortical bone makes up the 
outer shell of bone and predominates in the 
shafts of long bones.  Although each bone in the 
body contains both cortical and trabecular bone, 
the relative proportions differ.  In osteoporosis, 
both cortical thinning and a loss of trabecular 
support are evident (Wardlaw, 1993).  However, 
trabecular bone loss occurs at a greater rate 
thereby increasing fracture risk in areas where 
trabecular bone makes up the largest portion of 
the bone’s structure such as in the vertebrae, 
wrist, and the ends of long bones (i.e. the hip) 
(Boughton, 1999; Physicians Desk Reference 
(PDR), 1999; Smith, 1993; Wardlaw, 1993). 
 
Osteoporosis is not always a result of bone loss 
and can be characterized as either primary or 
secondary in nature.  Primary osteoporosis can 
occur in both genders at all ages but often 
follows menopause in women and occurs late in 
life in men (NIH, 2000).  Postmenopausal 
osteoporosis is known as primary osteoporosis 
Type I and is characterized by an increased bone 
resorption that primarily affects trabecular bone.  
Type I primary osteoporosis is directly linked to 
the decreased production of estrogen that 
coincides with menopause (Peterson, 2001; 
Wardlaw, 1993).  Rapid bone loss is osteoclast-
mediated and occurs in women within the first 5 
to 10 years after menopause (Peterson, 2001).  
Primary osteoporosis Type II is a slow bone loss 
resulting from a proportionate loss of trabecular 
and cortical bone usually due to a decrease in 
bone cell activity accompanying aging.  This 
type of osteoporosis predominately afflicts men 
and women over the age of 70 years and is 
called senile osteoporosis (Glaser & Kaplan, 
1997; Peterson, 2001; Wardlaw, 1993). 
 
Secondary osteoporosis usually occurs as a 
result of another disease or medication.  The 
most common medical conditions include 
chronic renal disease, hypogonadism, 
hyperthyroidism, Cushing’s disease, and some 
forms of cancer (Wardlaw, 1993).  Surgical 
procedures such as an early oophorectomy or 
total gastrectomy, can lead to bone loss.  
Additionally, some medications including 
anticonvulsants, corticosteroids, Depo-Provera, 
and Heparin, have toxic effects on bone and 
increase bone loss (Glaser & Kaplan, 1997; 
Kulak, Schussheim, McMahon, Kurland, 
Silverber, Siris, et al.., 2000; Peterson, 2001).  
Regardless of the cause of osteoporosis, the 
consequences are devastating to the financial, 
physical, and psychosocial aspects of one’s 
health (NIH, 2000; Donohue, 1999; National 
Osteoporosis Foundation [NOF], 2000; Moon, 
2000). 
 
Researchers agree that osteoporosis is not age- 
or gender-dependent in who it targets.  While 
white postmenopausal women have the highest 
incidence of osteoporotic fractures, and most of 
our knowledge about diagnosis and treatment is 
derived from research on this population, the 
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disease does not go unrecognized in other ages 
and races, or in men (Moon, 2000).  However, in 
comparison to men, women are at higher risk for 
developing osteoporosis and have a lifetime risk 
of an osteoporotic fracture as high as one in 
three (Mark & Link, 1999).  One third of women 
aged 65 and older will have at least one vertebral 
fracture in their lifetime and 33% will 
experience a hip fracture by age 90 
(Aufdemorte, 1991).  However, due to the 
diseases’ silent nature, there are few reliable 
statistics on how many women, including young 
women, are already developing low bone density 
and osteoporosis. A study conducted by Tokar 
and colleagues among a convenient sample of 
165 college-aged women found 1% of the 
participants to already have osteoporosis and an 
additional 14% of the participants to have low 
bone density or osteopenia (Tokar, Ford, Turner, 
& Denny, 2003).  
 
Osteoporosis is a condition normally associated 
with elderly women.  However, an increase in 
the number of women in their 20s and 30s 
suffering from osteoporosis has been reported 
(Hart & Dip, 1996).  Among postmenopausal 
women, factors associated with osteoporosis 
diagnoses include age, race, and family history 
(Turner et al., 1998).  Additional research 
indicates that other factors may also play a role 
in the development of this disease.  Among these 
are factors that are common among women who 
are younger than the age of menopause.  These 
other factors include low calcium intake, 
physical inactivity, smoking, excessive alcohol 
intake, use of steroid medications, and eating 
disorders (Hsieh, Novielli, Diamond, & 
Cheruva, 2001; Moon, 2000).  The development 
of osteoporosis is associated with many risk 
factors that transcend age. 
 
The prevention of osteoporosis is linked to 
strong bones being built during childhood and 
adolescence and being maintained throughout 
adult life (Mark & Link, 1999).  Since clinical 
manifestations of osteoporosis often do not 
appear until later in life, one of the most 
important factors in preventing osteoporosis is 
the attainment of an optimal peak bone mass 
during adolescence and young adulthood 
(Cromer & Harel, 2000).  Peak bone mass is 
defined as the highest level of bone mass 
achieved through normal skeletal growth (Masi 
& Bilezikian, 1997).  The achievement of peak 
bone mass occurs in the third decade of life; 
about the age of 30 (Masi & Bilezikian, 1997; 
NIH, 2000; PDR, 1999).  During the next 10-15 
years, the bone structure stays relatively stable 
with slight reductions in mass if certain lifestyles 
are practiced.  However, at the age of 
menopause, dramatic decreases in bone mass are 
lost due to changes in hormone production.  
Regardless of these hormonal changes, 
debilitating bone loss in not inevitable.  The 
physiologic processes that lead to osteoporosis 
occur over much of a patient’s lifespan and are 
amenable to interventions throughout that 
lifetime (Katz, & Sherman & DiNubile, 1998). 
 
The optimization of bone health is a process that 
must occur throughout the lifespan because once 
a woman experiences a fracture due to bone 
fragility, no known therapy can rebuild the 
damaged bone to a healthy level.  Therefore, 
measures taken to prevent bone fragility are of 
vital importance (Anderson & Metz, 1993; 
Blalock, et al., 1996).  Evidence indicates that 
young women can increase their peak bone 
mineral density, promote long-term bone health, 
and reduce the risk of disease later in life by 
following effective dietary exercise and lifestyle 
practices (Mark & Link, 1999).  Because there is 
currently no medical intervention to completely 
reverse the effects of osteoporosis, the most 
powerful tool to reduce the incidence of 
osteoporosis is prevention through health 
education (Mark & Link, 1999). 
 
Osteoporosis prevention programs have 
traditionally been marketed toward women later 
in life (postmenopause).  As a result, programs 
have emphasized nutritional changes, exercise 
programs, and hormone replacement therapy to 
prevent further bone loss.  Few, if any, programs 
have been developed specifically for younger 
women as a means of preventing this debilitating 
disease (Blalock et al., 1996; Jamal, Ridout, 
Chase, Fielding, Rubin, & Hawker, 1999).  This 
may be due to the seeming contradiction of 
young women having osteoporosis.  However, if 
young women are to prevent or delay the 
development and onset of osteoporosis in later 
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life, then osteoporosis prevention needs to begin 
decades before women experience menopause 
(Kasper, Peterson, Allegrante, Galsworthy, & 
Gutin, 1994).  A major component of such a 
prevention effort is education about behaviors 
that impact skeletal growth, the importance of 
regular menstrual cycles, proper nutrition, 
adequate physical activity, and cautions about 
medication use, smoking, and excessive alcohol 
intake. 
 
Diet and Osteoporosis 
Nutritional intake is a key component of 
osteoporosis prevention.  Several different 
dietary factors play a role in either the 
advancement or prevention of osteoporosis 
while still others negatively effect bone mass. 
 
Dietary Factors that Positively Effect 
Bone Health 
Calcium. The roles of calcium in nature are 
numerous.  This is also true when reviewing its 
roles in the human body.  Calcium’s most 
notorious role is that of structure or mechanics 
and is expressed in the mass, hardness, and 
strength of the bones and teeth (Weaver & 
Heaney, 1999).  This is further evident with 
more than 99% of the calcium in the body being 
used and present in bones and teeth (Wardlaw, 
1997).  Overall, calcium accounts for 1-2% of a 
person’s body weight (Weaver & Heaney, 
1999). 
 
The most documented and accepted health 
benefit of calcium is its role in bone health.  In 
bone, calcium exists primarily in the form of 
hydroxyapatite (Ca10(PO1)6(OH)2) (Weaver & 
Heaney, 1999).  When bones form, the calcium 
salts form crystals called hydroxyapatite, on a 
matrix of the protein collagen (Whitney & 
Rolfes, 2002).  As the crystal structure becomes 
denser, the strength and rigidity of the bones 
increase. 
 
Bone is a dynamic tissue that is constantly 
undergoing osteoclastic bone resorption and 
osteoblastic bone formation (National Academy 
Press (NAP), 2000).  In growing children, bone 
formation exceeds resorption.  This process is 
balanced in healthy adults while formation lags 
behind resorption after menopause and with 
aging in men and women (NAP, 2000).  The 
skeleton has an obvious structural role and also 
serves as a reservoir for calcium. 
 
Deficiency is the most widely known issue 
associated with calcium intake.  A chronic 
inadequate calcium intake through diet or 
supplementation is one factor in the etiology of 
several disorders.  The disorder given the most 
attention is osteoporosis. This disease is 
multifaceted with many correlated risk factors 
such as smoking, glucocorticoid use, and 
physical inactivity (Swaminathan, 1999).  
However, many of these risk factors influence 
calcium uptake and utilization.  Yet the role of 
calcium intake in the prevention of osteoporosis 
can be reduced to two basic principles: build the 
highest peak bone mass possible and protect the 
bone mass that has accumulated (Heaney, 1992). 
 
Low calcium intakes coupled with high 
obligatory calcium losses from the body, deplete 
calcium reserves.  In other words, low intakes 
cause subnormal bone mass and strength.  This 
is one of the contributing factors of osteoporosis.  
The primary strategies for reducing osteoporosis 
risk are to optimize bone mass during growth 
and to reduce bone loss later in life.  The aim of 
both of these strategies is to maximize calcium 
intakes (Weaver & Heaney, 1999; Krall & 
Dawson-Hughes, 1999).  In the past few years, 
evidence has been given to indicate that dietary 
calcium intake is positively related to bone 
mineral density in children and adolescents.  
Research indicates the higher the calcium intake, 
the greater the peak bone mass (Valimaki et al., 
1994; Jackman et al., 1997).  Additionally, 
research has indicated a positive correlation 
between bone mass and calcium intake in 
premenopausal adult women (Welten, Kemper, 
Post, & Van Staveren, 1995).   Overall, there is 
strong evidence that calcium intake influences 
bone mass in all age groups (Gennari, 2001). 
 
Adequate dietary calcium is essential for 
building denser, stronger bones in the first three 
decades of life and for slowing the rates of bone 
loss in later years (Gerrior et al., 1998).  The 
importance of calcium in the human diet is 
evident in many government publications.  
Healthy People 2010 is a document created to 
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identify the current health status of Americans 
and the health and lifestyle areas needing 
improvement.  One of the goals of the Healthy 
People 2010 document is to increase the quality 
of life among Americans.  This is important 
when evaluating calcium intake and its role in 
the development of osteoporosis.  As a result, 
there are three calcium-related objectives 
outlined in Healthy People 2010.  One of these 
is specific to calcium intake while the other two 
are related to osteoporosis. 
 
Objective 19-11.  Increase the proportion of 
persons aged two years and older who meet 
dietary recommendations for calcium. 
 
Calcium is essential for various mechanic and 
physiologic functions in the body.  According to 
the Institute of Medicine (IOM) (1997), and the 
new Dietary Reference Intakes, the 
recommendations for adequate daily intakes 
(AIs) of calcium are 500 milligrams for children 
one to three years.  The recommendations for 
other age groups include children aged four to 
eight years, 800 milligrams; for adolescents aged 
nine to 18 years, 1300 milligrams; for adults 19 
to 50 years, 1000 milligrams; and for adults 
older than 51 years, 1200 milligrams (IOM, 
1997). 
 
According to baseline data collected during the 
National Health and Nutrition Examination 
Survey of 1988-1994 (NHANES III), only 46% 
of persons aged two years and older were at or 
above approximated mean calcium requirements 
based on calcium from foods, dietary 
supplements, and antacids.  By the year 2010, 
the target for adequate calcium intake is 75% of 
the population agedtwo years and older. 
 
Sources of dietary calcium are numerous.  The 
most often recognized form is that of dairy 
products.  Milk products contribute a significant 
proportion of calcium to the diets of women in 
western societies and women who do not 
consume milk products are unlikely to meet their 
calcium needs (Fleming & Heimbach, 1994; 
Horwath, Bovern, Campbell, Busby, & Scott, 
1995).  Several barriers to milk product 
consumption have been identified in research.  
Low consumption has been associated with a 
dislike for milk products (Horwath et al., 1995), 
adverse reactions such as lactose intolerance 
(Arney & Pinnock, 1993), perceived adequate 
intake (Chapman, Chan, & Clark, 1995), and the 
perception of milk products increasing dietary 
fat and cholesterol intake (Horwath et al., 1995).  
However, research has also identified that 
consuming more meals at home or at sit-down 
restaurants is associated with moderate calcium 
intake (Lewis & Hollingworth, 1992). 
 
The barrier to dairy product intake related to 
increasing fat and cholesterol is important to 
highlight.  Many young women engage in self-
imposed energy reduction diets.  As a result, 
they are at risk for not obtaining an adequate 
calcium intake level.  In a study conducted in 
Australia, researchers found that 68% of the 18-
year-old university students in the study had 
calcium consumption levels below 800mg.  The 
majority of these women were on energy-
reduction diets and at risk of a dietary calcium 
intake deficit at a time when calcium intake 
should be enhanced (Portsmouth, Henderson, 
Graham, Price, Cole, & Allen, 1994).  Dietary 
modification in the form of dairy products is 
important to consider.  A three-year prospective 
study found that increasing dairy product 
consumption retards vertebral bone loss in 
premenopausal women (Baran et al., 1989).  
Dairy products are the richest source of dietary 
calcium and need to be consumed to assist 
women in achieving adequate calcium intake.  In 
fact, research indicates the most people obtain 
50% of their calcium from dairy products 
(Wardlaw & Weese, 1995). 
 
Calcium supplementation is another effort 
utilized to meet the published Healthy People 
2010 objectives.  Interest and enthusiasm in the 
use of dietary supplements appears to be 
growing in the United States.  According to 
NHANES III data collected in 1988-1994, 
approximately 40% of the population took 
dietary supplements during the month prior to 
the interview (Ervin, Wright, & Kennedy-
Stephenson, 1999). Characteristics of these 
supplement users included women, Caucasian, 
increasing age, higher levels of income and 
education, and a self-reported health status of 
good or fair.  Of these supplement users, 
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approximately 46 percent took a combination 
vitamin/mineral product (Ervin et al., 1999).  
The data did not indicate the proportion of 
people consuming calcium supplements alone. 
 
Calcium supplements are a nondietary, 
alternative source of calcium (Sutton, 2000).  
Individuals who are unable to get enough 
calcium in their regular diet generally take 
calcium supplements.  These nondietary 
alternatives often come as a salt.  A calcium 
“salt” contains calcium along with another 
substance, such as carbonate or gluconate 
(Micromedex, 2001).  As a result, some calcium 
salts have more elemental calcium than others. 
 
Studies examining the effects of calcium 
supplementation in premenopausal women have 
shown conflicting results.  Some have shown no 
significant effect on bone mineral density 
(BMD) in premenopausal women (Smith, 
Gilligan, Smith, Surpos, 1989) while still others 
have shown significant increases in BMD 
(Baran et al., 1989; Rico, Revilla, Villa, de 
Buergo, & Arribas, 1994; Lloyd et al., 1993; 
Johnston et al., 1992).  Although there have been 
discrepancies in the findings, the overall 
conclusion is that calcium intake, even from 
supplements, has some effect in increasing peak 
bone mass during growth and bone maturation. 
 
Although calcium supplements have a role in 
achieving adequate calcium intake, it is 
important to remember that the best source of 
calcium is food.  A calcium supplement is to 
supplement what is obtained from food sources.  
Additionally, it is important to remember that 
bone health is not based on a single nutrient 
(Heaney, 1992).  Diets low in calcium also tend 
to be low in other nutrients that are essential for 
normal bone development such as zinc, 
manganese, copper, ascorbic acid, protein, and 
vitamin D (Holbrook, & Barrett-Connor, 1991). 
 
The need for knowledge is extensive.  Calcium 
intake is vital for the current and future health of 
individuals.  Information about how to obtain 
adequate calcium intakes is vital for several 
subpopulations such as vegetarians, lactose 
intolerant individuals, ethnic groups, and young 
women.  Education about calcium needs to be 
expanded throughout one’s life because research 
indicates that bone mass can increase through 
the third decade of life (Recker, Davies, 
Hinders, Heaney, Stegman, & Kimmel, 1992). 
 
Vitamin D. Vitamin D plays an important role 
in calcium metabolism, calcium absorption, and 
bone health.  The National Osteoporosis 
Foundation describes the relationship between 
calcium absorption and vitamin D as being 
similar to that of a locked door and key (NOF, 
n.d.).  Vitamin D is the key that unlocks the door 
and allows calcium to leave the intestine and 
enter the bloodstream.  Vitamin D also works in 
the kidneys to help resorb calcium that otherwise 
would be excreted (NOF, n.d.). 
 
Vitamin D is a fat soluble vitamin that has been 
associated with bone-related disorders for 
centuries.  Vitamin D deficiency is associated 
with rickets in children, osteomalacia in adults, 
and secondary hyperparathyroidism (Combs, 
1998).  The daily requirement for this vitamin is 
met from the diet or from synthesis in the skin.  
From either of these sources, vitamin D is 
metabolized to 25-hydroxy vitamin D (25OHD) 
in the liver and is then converted to the active 
metabolite 1,25 dihydroxyvitamin D (1,25 [OH2 
D) in the kidney (Combs, 1998; Swaminathan, 
1999). 
 
Recommendations for vitamin D intake are 200 
international units (IU) for women under the age 
of 50, 400 IU for women 51-70 years of age, and 
600 IU for women over 70 years of age 
(Willhite, 1998).  The increase in vitamin D 
intake recommendations indicates that ageing 
affects vitamin D metabolism.  The conversion 
of 25OHD to the active metabolite 1,25(OH)2D 
is reduced because of an age-related decline in 
renal function (Swaminathan, 1999).  
Additionally, as adults age, the ability to make 
vitamin D through the skin decreases (NOF, 
n.d.). 
 
There are many sources of vitamin D available, 
however sunshine is the major source.  One 
study indicated that total body sun exposure 
could provide the equivalent of 10,000 IU of 
vitamin D without a person experiencing 
toxicity.  The study suggested that the RDA for 
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vitamin D is a physiologic limit (Vieth, 1999).  
It may be important to note that sources of 
vitamin D may be managed differently in the 
body and therefore, the body can handle a 
greater amount of sunlight produced vitamin D 
than vitamin D from dietary sources.  However, 
dietary sources of vitamin D are necessary to 
utilize by people who do not get adequate sun 
exposure due to latitude, season, work 
environment, etc.  Dietary sources of vitamin D 
include vitamin D-fortified dairy products, egg 
yolks, saltwater fish, liver, and supplements 
(Dowd, 2001; NOF, n.d.; Willhite, 1998). 
 
Vitamin D enhances calcium’s ability to build 
and maintain bones. Several studies have 
indicated the importance of vitamin D as a 
partner with calcium in the prevention of 
osteoporotic fractures. Vitamin D in 
combination with calcium has been shown to 
increase bone density and decrease fracture rates 
(Dawson-Hughes, Harris, Krall, & Dallal, 1997; 
Chapuy et al., 1992).  Additionally, vitamin D 
supplementation has demonstrated an increase in 
bone mineral density (Dawson-Hughes, Harris, 
Krall, Dallal, Falconer, & Green, 1995; Ooms, 
Roos, Bezemer, Van Der Vijgh, Bouter, & Lips, 
1995). 
 
Vitamin D has a vital role in the health of bone.  
The role of this fat soluble vitamin is important 
for the absorption and utilization of calcium 
which is the primary mineral in bone.  
Therefore, it is important for individuals to be 
knowledgeable about the interaction of this 
vitamin and mineral for total bone health.  
Young women run the risk of being deficient in 
vitamin D if they avoid the sun or fail to 
consume adequate dietary sources.  In other 
words, if women avoid consuming dairy 
products, they not only lose out on the calcium 
content but also the possibility for vitamin D 
consumption. 
 
Fluoride. Fluoride has effects on the matrix of 
bone itself and on osteoblast function.  Although 
fluoride has been used for dental carry 
prevention, it is approved for the treatment of 
osteoporosis in many countries around the world 
(Dowd, 2001; Sowers, Wallace, & Lemke, 
1986).  Fluoride is capable of stimulating 
osteoblasts to increase bone formation.  
Although the new bone has increased 
crystallinity, making it more resistant to 
resorption, the bone formed is abnormal and 
mechanical strength is compromised (Willhite, 
1998).  A clinical trial study demonstrated this 
compromise of mechanical strength by utilizing 
immediate-release fluoride.  The study showed 
gains in spinal bone mineral density but spinal 
fracture rate was not decreased.  Additionally, 
fracture risk of the hip and appendicular skeleton 
actually increased (Pak, Sakhaee, Rubin, 
Zerwekh, 1997).  The authors concluded that 
fluoride may increase trabecular bone density at 
the expense of cortical bone even with adequate 
calcium supplementation (Pak et al., 1997). 
 
Additional studies have been conducted using 
sustained-release fluoride.  A study conducted 
by Pak and colleagues (1995) looked at 
osteoporotic women consuming sustained-
release sodium fluoride and calcium citrate for 
four years.  The study found an increase in 
spinal BMD by almost 5% and a decrease in 
vertebral fracture rate when compared to 
calcium intake alone (Pak, Sakhaee, Adams-
Huet, Piziak, Peterson, Poindexter, 1995). 
 
Fluoride is a compound that aids in the 
development of a strong bone structure.  
However, studies indicate that fluoride alone can 
actually reduce bone strength.  The research 
further indicates that in combination with other 
minerals and vitamins such as calcium and 
vitamin D, fluoride has its greatest benefits for 
bone health. 
 
Other positive dietary factors. Several other 
vitamins and minerals play a key role in the 
health of bone and therefore the prevention of 
osteoporosis.  It is important to discuss these 
compounds because it supports the fact that bone 
formation and health is a complex and 
multifaceted process.  It is important for one to 
have good overall health and to achieve such a 
status through adequate dietary intake.  Simply 
taking supplements of various vitamins and 
minerals does not allow for adequate or 
appropriate nutritional balance to assist in 
adequate bone health. 
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Vitamin K has been suggested to play a specific 
role in osteoporosis.  Vitamin K is involved in 
the synthesis of various proteins in the body 
including three in bone tissue: osteocalcin, 
matrix gla protein (MGP) and protein S (Dowd, 
2001; Swaminathan, 1999).  Vitamin K-
dependent proteins contain gamma 
carboxyglutamic acid residues, and vitamin K is 
required for the carboxylation reaction of 
glutamic acid (Combs, 1998; Swaminathan, 
1999).  A lack of vitamin K will lead to a 
reduction in carboxylation of vitamin K-
dependent proteins.  The concentration of 
undercarboxylated osteocalcin (UcOC) has been 
reported to be higher in postmenopausal women 
than in premenopausal women (Knapen, 
Hamulyak, & Vermeer, 1989) and there seems 
to be an increase in UcOC with age (Plantalech, 
Guilaumont, Vergnaud, Leclercq, & Delmas, 
1991).  Additionally, elevated UcOC 
concentrations have been associated with low 
bone mass in the femur and an increased risk of 
hip fracture in elderly women (Szulc, Arlot, 
Chapuy, Duboeuf, Meunier, & Delmas, 1994; 
Szulc, Chapuy, Meunier, Delmas, 1993). 
 
Vitamin K is also known for its role in blood 
clotting.  For those who are taking 
anticoagulants, caution needs to be exercised 
when taking supplemental Vitamin K because it 
could affect clotting.  A physician should be 
consulted prior to taking supplemental vitamin 
K.  The major dietary source of vitamin K is 
green vegetables (Combs, 1998).  Although 
vitamin K deficiency is rare in most societies 
and its role in bone health is not completely 
clear, vitamin K cannot be ignored as a 
compound of importance in bone health. 
 
Phosphorus is another compound that is 
important for bone health.  Phosphorus is widely 
available in the diet and is part of the crystal 
structure of bones.  Almost 85% of the body’s 
phosphorus is present in crystalline form in bone 
as hydroxyapatite (Gennari, 2001). Since 
phosphorus is so abundant in the diet, a 
nutritional deficit is generally not a concern.  
However, among those with malnutrition or low 
dietary calcium intakes, phosphorus may bring 
harm by causing an increased calcium excretion 
(Dowd, 2001). 
 
Phosphorus deficiency may be more important 
than currently recognized.  Multiple nutritional 
deficiencies have been implicated in the 
concentrated number of fractures of the upper 
femur (Combs, 1998).  With approximately 20% 
of elderly individuals in industrialized nations 
ingesting less than 60% of the RDA for 
phosphorus or protein, a relative 
hypophosphatemia might result (Heaney, 2000).  
This inadequate phosphorus intake could slow 
bone repair of osteoporotic fractures (Dowd, 
2001).  When searching for a good source of 
phosphorus, it is important to know that milk 
provides calcium and phosphorus in an optimal 
ratio for building bone tissue (Dowd, 2001). 
 
The final mineral to be discussed in relation to 
bone health is magnesium.  Approximately 50-
60% of the magnesium in the body is in bone 
(Gennari, 2001).  A well-balanced diet including 
whole grains, legumes, green leafy vegetables, 
and nuts contains a healthy amount of 
magnesium (Dowd, 2001).  Although many 
people do not consume an adequate amount of 
calcium in their diet, magnesium deficiency is 
relatively rare (Combs, 1998; Dowd, 2001). 
 
In experimental magnesium deficiency studies, 
osteoblastic and osteoclastic activity is 
decreased and there is a cessation of bone 
growth and osteopenia develops (Robbins & 
New, 1997).  Additionally, the magnesium 
content of trabecular bone in osteoporotic 
subjects is significantly lower than other 
subjects and magnesium intake has been 
reported to be lower in osteoporotic subjects 
(Combs, 1998; Schwartz & Reddi, 1979). 
 
In addition to its content in bone, magnesium 
plays a role in the formation of 1,25 
dihydroxyvitamin D.  A magnesium-dependent 
hydroxylase enzyme is involved in the formation 
of 1,25 dihydroxyvitamin D.  Therefore, if a 
magnesium deficiency did occur as in those with 
serious illness, alcoholism, prolonged vomiting 
and diarrhea, or intestinal malabsorption, this 
could possibly adversely affect calcium 
absorption and therefore bone strength (Combs, 
1998; Dowd, 2001; Risco, Traba, de la Piedra, 
1995). 
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Dietary Factors that Negatively Effect Bone 
Health 
Protein. Protein-energy malnutrition during 
childhood or adolescence may retard growth and 
reduce body strength and peak bone mass (Toss, 
1992).  However, it has also been suggested that 
a high-protein diet may increase the risk of 
osteoporosis as a result of increases in urinary 
calcium excretion (Lau & Woo, 1998).  The 
mechanism of increased urinary calcium 
excretion is thought to be a result of glomerular 
filtration rate (GFR) and the acid load from the 
sulphur containing amino acids methionine and 
cysteine (Marcus, 1982).  This increase in 
endogenous acid production mobilizes calcium 
from the skeleton to form salts to neutralize the 
acidity (Krieger, Sessler, & Bushinsky, 1992). 
Concerns about high-protein diets arose when 
studies showed increases in urinary calcium 
excretion (Heaney, 1993).  Although there is 
little evidence from clinical trials to support the 
observation that high dietary protein intake 
causes increased bone loss, result of 
observational epidemiologic studies do support 
this view.  Results from two ecologic studies 
indicate that the incidence of hip fracture is 
inversely related to the per capita consumption 
of protein (Abelow, Holford, & Insogna, 1992; 
Hegsted, 1986).  While it is difficult to interpret 
these results because of the numerable 
confounding effects of other dietary 
components, these studies still lend concern to 
the issue of protein intake and osteoporosis 
development. 
 
The average protein intake in many 
industrialized countries, including the U.S., is at 
least 50% above recommended levels (Krall & 
Dawson-Hughes, 1999).  An average increase in 
dietary protein of 1 gram results in the loss of an 
additional 1 milligram of calcium in the urine 
(NAP, 2000; Krall & Dawson-Hughes, 1999).  
Such calcium losses could be important for 
individuals with a low usual calcium intake or 
impaired calcium absorption.  Current 
recommendations would result in a dietary 
calcium/protein intake ratio of 20mg calcium/1 g 
protein (Heaney, 1998; IOM, 1997). 
 
While protein has been shown to increase 
calcium excretion, its roles in calcium 
absorption and retention are controversial.  A 
twenty-year study conducted by Heaney (2000), 
on Catholic nuns, concluded that protein intakes, 
within the current U.S. intake levels, do not 
affect calcium absorption.  The research related 
to protein’s influence on osteoporosis is still 
controversial, but two things are known for sure: 
a) protein is necessary for bone and muscle 
health, and b) high levels of protein intake 
increase urinary calcium excretion (Powers et 
al., 1999). 
 
Sodium. Sodium and calcium excretion are 
linked in the proximal renal tubule.  Sodium 
causes an increase in renal calcium excretion 
(Krall & Dawson-Hughes, 1999).  For each 500-
milligram increment in sodium excretion or 
intake, there is approximately a 10-milligram 
increase in the amount of calcium lost in urine 
(NAP, 2000). 
 
A study conducted by Devine and colleagues 
(1995) on postmenopausal women, 
demonstrated the impact of sodium intake on the 
rate of bone loss at the hip.  The study identified 
an increasingly negative change in hip bone 
density with higher urinary sodium levels and 
with increasing sodium intakes between 1 and 6 
grams per day.  The study further suggested that 
halving the current sodium intake of 121 mmol/d 
(or 2700 mg/day) would be equivalent to 
increasing dietary calcium by 22 mmol/d (or 890 
mg/day) (Devine, Criddle, Dick, Kerr, & Prince, 
1995).  However, a study of pubertal females 
found no association between bone mineral 
density and urinary sodium excretion (Matkovic 
et al., 1995). 
 
Studies correlating high sodium intake with a 
decrease in bone mineral density raise concern 
due to the high salt content of processed foods 
and the quantity of these foods that Americans 
consume.  Reassuring information from a study 
by Massey and Whiting (1996) was that calcium 
intakes between 1000 milligrams and 2000 
milligrams minimized bone loss in the hip area 
associated with diets high in sodium.  These 
calcium levels are within the new Dietary 
Reference Intakes (DRIs) recommendations and 
do not exceed the Tolerable Upper Limit values 
(ULs). 
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Caffeine. The consumption of caffeine and its 
relationship to bone health is a controversial 
topic.  Caffeine is the most widely consumed 
psychoactive substance in the world with coffee 
supplying greater than 80% of the caffeine 
consumed by adults in the United States (Barone 
& Grice, 1994).  Numerous studies have 
reported on caffeine as a possible risk factor for 
bone loss in adult women.  The results however 
have been contradictory. 
 
Several studies have reported no association 
between caffeine intake and fracture frequency 
or changes in bone density (Johansson, 
Mellstrom, Lerner, & Osterber, 1992; Lloyd, 
Rollings, Eggli, Kieselhorst, & Chinchilli, 1997; 
McCullock, Bailey, Houston, & Dodd, 1990; 
Tavani, Negri, & LaVecchia, 1995).  Others, 
however, have reported small but significant 
increases in either fracture frequency or bone 
loss.  The most notable of these studies is the 
Framingham study that reported a 53% greater 
incidence of hip fracture in those who consumed 
more than two cups of coffee or four cups of tea 
after controlling for weight, sex, age, estrogen 
use, smoking and alcohol (Kiel, Felson, Hannan, 
Anderson, & Wilson, 1990). Another 
noteworthy study was the Nurses Health Study 
of 84,000 women who were followed for 6 
years.  The study found that women with the 
highest intake of coffee and the highest intake of 
caffeine (800 mg or more daily) had three times 
the rate of hip fractures as the no coffee/no 
caffeine group (Hernandez-Avila, Colditz, 
Stampfer, Rosner, Speizer, & Willett, 1991). 
 
Caffeine ingestion causes a short-term (within 
1—3 hours) increase in urinary calcium loss, but 
studies have failed to document sustained effects 
of caffeine on urinary or fecal calcium excretion 
(Krall & Dawson-Hughes, 1999).  Among 
people who have low calcium intakes the effect 
may be of great importance as the body fails to 
adequately compensate for the additional 
calcium loss. 
 
The effects of caffeine on bone mass in young 
women have also been a controversial topic.  A 
study conducted by Packard and Recker (1996) 
indicated that a moderate caffeine intake (one 
cup of coffee per day or 103 mg) appeared to be 
a safe level with respect to bone health.  
However, another study conducted by Conlisk 
and Galuska (2000) did find that caffeine 
consumption decreased bone mineral density at 
various skeletal sites.  The study indicated that 
for every 100 mg of caffeine consumed, femoral 
neck BMD decreased 0.0069 g/cm2, and lumbar 
spine decreased 0.0119 g/cm2 (Conlisk & 
Galuska, 2000).  Although there was no 
significant difference between those who 
consumed low levels of calcium and those who 
consumed high levels of calcium in this study, it 
stands to reason that such decreases over many 
years can increase a woman’s risk of 
osteoporosis significantly. 
 
Although sustained effects of caffeine on 
calcium excretion have not been observed in 
these studies, there is another aspect of this 
consumption that needs consideration; beverage 
replacement.  On any given day, half of all 
Americans drink carbonated soft drinks 
according to data collected for 1994-1996 
(Gerrior et al., 1998).  The intake of these 
beverages has increased drastically among 
teenagers, younger adults, and women drinking 
low-calorie beverages, since 1970.  Annual food 
supply data show that per capita consumption of 
regular carbonated soft drinks increased from 22 
gallons in 1970 to 40 gallons in 1994 and to 41 
gallons in 1997 (Gerrior et al., 1998).  Whether 
caffeine affects over all calcium excretion is 
important, but the fact that carbonated beverages 
are replacing calcium-rich drinks needs 
consideration.   
 
Long-term effects of frequent caffeinated 
beverage intake must be conducted before a 
consensus about the true relationship between 
caffeine and calcium can be decided upon.  If 
caffeine increases calcium excretion for 1-3 
hours, it stands to reason that a person who 
consumes 3-4 caffeinated beverages a day will 
have a significant loss of calcium in their urine. 
Dietary Factors with Questionable Effects on 
Bone Health 
 
Soy and isoflavones. Phytoestrogens such as 
isoflavones, which are found in many soy foods 
and supplements, have a chemical structure that 
causes them to act in the body like the estrogenic 
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hormone estradiol (Anderson, 1999; Messina, 
1995; Messina, 1999).  The lower rate of hip 
fracture among Japanese women in comparison 
to US women is often cited as providing support 
for the protective effect of isoflavones (Ross et 
al., 1991).  However, this argument is without 
merit (Messina, 1999).  
 
There is some evidence that soy may reduce 
bone turnover as measured in urine and serum 
bone markers (Alekel, St. Germain, & Peterson, 
2000; Pennington & Schoen, 1996; Messina, 
Gardner, & Barnes, 2002).  However, 
researchers at Creighton University found no 
effect on spine and femur bone mineral density 
in early postmenopausal women (Heaney, 
Dowell, Rafferty, & Bierman, 2000).  Although 
soy has nutritional value, its effects on bone 
seem to be small and of tentative clinical 
importance. 
 
Several studies have been conducted to compare 
the antiresporptive effect of estrogen 
replacement in postmenopausal women versus 
that of soy isoflavones (Heaney et al., 2000; 
Setchell, 2000).  However, in both of these 
studies, there was not a greater bioavailability of 
soy isoflavones.  In fact, calcium in fortified soy 
milk was not absorbed as efficiently as calcium 
from non-soy milk. 
 
Although several animal studies indicate a 
potential benefit in the inhibition of bone 
resorption as a result of soy isoflavones 
(Anderson, Ambrose, &  Garner, 1995; Brandii, 
1992) there have not been consistent results 
when applied in human models.  There are 
several areas left unanswered that are necessary 
to delineate the effects of soy fully or to allow 
making any recommendations (Dowd, 2001).  
Information regarding efficacy, safety, which 
isoflavones have the greatest effect, and amounts 
of isoflavones necessary for measurable benefit, 
are necessary to provide accurate 
recommendations. 
 
Conditions That Effect Dietary Intake 
Lactose Intolerance. About 25% of adults in 
the United States have lactose intolerance and 
develop symptoms of diarrhea and bloating after 
ingestion of a large dose of lactose (NAP, 2000).  
This condition is caused by a deficiency of an 
enzyme that breaks down milk sugar in the 
intestine called lactase.  Many people believe 
they are lactose intolerant, but they do not know 
they do not have to be.  Lactose intolerance is 
especially common in African Americans, 
Hispanics, Native Americans, and Asian 
Americans (Gerrior et al., 1998).  Those who 
demonstrate lactose intolerance often avoid 
dairy products entirely.  However, such foods as 
hard cheese (Swiss, cheddar, American), yogurt, 
and lactose-reduced milk have lower lactose 
levels and therefore can be consumed by 
sufferers of lactose intolerance (Dowd, 2001).  
In addition, studies indicate that many lactose-
intolerant people can tolerate smaller doses of 
lactose such as the amount present in an 8-ounce 
glass of milk without the negative side effects 
(Levin, 1999; NAP, 2000). 
 
Lactose-intolerant individuals absorb calcium 
normally from milk, but they are at an increased 
risk of calcium deficiency because of their 
avoidance of milk and other calcium rich dairy 
products (NAP, 2000).  Although lactose 
intolerance may influence intake, there is no 
evidence to suggest that it influences the calcium 
requirements (NAP, 2000).  Therefore, to aid in 
calcium intake, lactose-free dairy products are 
available.  There are also good nondairy sources 
of calcium such as canned salmon with the 
bones, fortified cereals, and calcium-fortified 
orange juice. 
 
Nutritional Summary 
Nutrition plays a significant role in the cause 
and prevention of osteoporosis.  This disease can 
be prevented by maintaining an optimal calcium 
intake, maintaining an adequate vitamin D level, 
avoiding a high salt intake, and avoiding 
extremely high animal protein intakes. Nutrition 
through food consumption is the most adequate 
method to achieve good bone strength.  The 
bone matrix is complex and simply taking a 
supplement or several supplements to possibly 
compensate for an inadequate diet, could cause a 
greater imbalance and still lead to a weak bone 
mass.  Nutritional factors alone do not 
completely explain the prevention puzzle of 
osteoporosis.  Additional factors such as 
physical activity, heredity, and ethnicity play a 
 11
J. Freeman & L Turner / Californian Journal of Health Promotion 2004, Volume 2, Issue 3, 12-29 
 
role in understanding the etiology and 
prevention of the disease. 
 
Lifestyle Factors and Osteoporosis 
Physical Activity 
Bone is living tissue that responds to exercise by 
becoming stronger and denser.  There are two 
types of exercises that are important for building 
and maintaining bone strength and density: 
weight-bearing and resistance exercises (NOF, 
2000).  The specific characteristics of physical 
activity that are most important for influencing 
bone are not completely understood, but 
research indicates that high mechanical loads 
may be more osteotropic than low-intensity 
loads (Taaffe, Robinson, Snow, & Marcus, 
1997).  Additionally, the number of repetitions 
has been shown to make modest effects of bone 
mass (Carter, Fyrie, & Whalen, 1987; Rubin & 
Lanyon, 1985). 
 
However, conclusions about the effects of 
exercise in the prevention of osteoporosis are 
still vague.  Research seems to be inconclusive 
about the types of recommendations that should 
be made.  The majority of osteoporosis 
researchers would probably agree that 
recommending physical activity is important for 
improving balance, muscle tone, flexibility, 
strength, and coordination; all aspects that could 
prevent falls and low-trauma fractures 
(American College of Sports Medicine [ACSM], 
1995).  Yet questions remain as to what types of 
activities, for how long, how often, at what 
intensity, and should the activities be site 
specific?  Much research exists that indicates 
simply physical activity in itself can help 
prevent osteoporosis. 
 
As with other areas of osteoporosis research, a 
lot of information is available for older 
populations. The few studies that exist for 
younger, premenopausal women lend support to 
the information that has been acquired while 
studying older populations. In a study conducted 
by Turner and colleagues, women who 
participated in the NHANES III study over the 
age of 50 were reviewed.  The study identified 
physical activity as a greater predictor for 
fracture than heredity, smoking status, alcohol 
use, and dairy product intake (Turner, Leaver-
Dunn, DiBrezzo, & Fort, 1998).  The study 
revealed that inactive women were 84% more 
likely to suffer a fracture than females who were 
active 2 or more times per week. 
 
Another study conducted by Mitchell and 
colleagues followed 2,567 women for an 
average of 11 years.  This study reviewed the 
risk of developing osteoporosis based on 
cardiorespiratory fitness.  The study revealed 
that the more fit a woman was, the less likely 
she was to develop physician diagnosed 
osteoporosis during the time frame of the study.  
After the researchers adjusted for age, body 
mass index, high blood pressure, cigarette 
smoking, alcohol consumption, and diabetes, 
they found that low fit women were 1.8 times 
more likely to develop osteoporosis than 
moderate or high fit women (Mitchell, Wei, 
Gibbons, & Blair, 1999). 
 
Studies reviewing the types of activities women 
participate in and their risk for osteoporosis have 
also been conducted.  One study recently 
published by Turner and colleagues (2002) 
indicated that yard work and weight training 
were strong and independent predictors for 
positive bone density.  Again, data from the 
Third National Health and Nutrition 
Examination Survey (NHANES III) were used 
to study the relationship between exercise mode, 
frequency, and bone health (Turner, Bass, Ting, 
& Brown, 2002).  Other activities were also 
identified as moderate predictors for positive 
bone density such as bicycling, aerobics, 
walking, and dancing (Turner et al., 2002). 
 
Most of the data related to young adult women 
between the ages of 18-35 comes from cross-
sectional studies comparing bone mineral 
density (BMD) of female athletes to that of a 
sedentary group.  Direct measurements of bone 
mass have shown a positive correlation between 
spinal BMD and reported leisure time activity in 
healthy young women (Kanders, Dempster, & 
Lindsay, 1988).  In this study, calcium and 
physical activity were independent determinants 
of BMD. 
 
There have been few prospective studies of an 
exercise effect on bone mass in this age group.  
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In a study conducted by Snow-Harter and 
colleagues (1992), jogging or aerobic exercise 
for 20-30 minutes three times a week increased 
lumbar spinal bone mineral density by 1 percent 
in premenopausal women.  Additionally, a study 
conducted by Bassey and Ramsdale (1994) 
found a significant increase of 3.4% in 
trochanteric bone density in a group of high-
impact exercisers when compared to low-impact 
exercisers.  Although these increases may seem 
to be small, any increase in bone mineral density 
that can delay the onset of osteoporosis or the 
complications of low bone density are important 
to consider and should not be discarded as being 
without merit. 
 
Studies of athletes show that the BMD of loaded 
bones can be more than 30% higher in most 
studies and between 5% and 20% higher in most 
sites than that of unloaded bone or of the same 
bones in non-athletic control subjects (Vuori, 
1996). However, for young women who are 
high-performance athletes, physical activity may 
increase their risk of osteoporosis. Intensive 
training that results in an extreme loss of body 
fat, disordered eating and estrogen deficiency 
can lead to bone loss (Vuori, 1996). The 
combination of osteoporosis, menstrual 
irregularities, and disordered eating is known as 
the female athlete triad (Sabatini, 2001).  
Many young female athletes experience a 
cessation in their menstrual cycles called 
amenorrhea.  Several studies have reported low 
bone densities among these women (De Cree, 
Vermeulen, & Ostyn, 1991; Licata, 1992; Fabbri 
et al., 1991).  Low bone densities result in a 
greater risk for stress fractures and other more 
devastating fractures of the hip and spine (Bass, 
Turner, & Hunt, 2001).  Furthermore, research 
has indicated that premature osteoporosis 
occurring in female athletes may be irreversible 
even with calcium supplementation, resumption 
of menses, or estrogen replacement therapy 
(Drinkwater, Bruemner, & Chestnut, 1990). 
 
The extent of exercise’s influence on 
osteoporosis and its ability to induce bone 
density increases is still uncertain.  Results from 
these studies vary according to age, hormonal 
status, nutrition, and exercise prescription.  
Regardless of the uncertainty from research 
results, expert panels such as the American 
College of Sports Medicine, recommend weight-
bearing activity and activities that improve 
strength, flexibility, and coordination to prevent 
osteoporosis and falls respectively (ACSM, 
1995). 
 
Alcohol Intake 
Studies have indicated that alcohol suppresses 
bone formation.  Since women are more prone to 
osteoporosis than men, the effects of alcohol 
may have a greater effect on their bones 
(Laitinen, Karkkainen, Lalla, Lamber-Allardt, 
Tunninen, Tahtela, et al., 1993).  The evidence 
for the adverse effects of alcohol on bone 
mineral density (BMD) comes primarily from 
case control studies.  However, in a 14-year 
longitudinal study, the rate of bone loss in men 
who drank regularly was faster than in controls 
(Slemenda, Christina, Reed, Reister, Williams, 
& Johnston, 1992).  Similarly, BMD in 
premenopausal women who drank regularly was 
also found to be lower than in matched controls 
(Arden, 1997). 
 
Alcohol is capable of increasing one’s risk of 
osteoporosis or fracture through several different 
methods.  First, alcohol abuse may bring about 
hypoestrogenism with consequent menstrual 
irregularities and amenorrhea (Mello, 
Mendelson, & Teoh, 1989; Van Thiel & 
Gavaler, 1990).  These irregularities can depress 
osteoblastic activity (Lappe, 1994).  This can 
lead to an imbalance between the resorptive 
osteoclastic activity and the formative 
osteoblastic activity progressing to decreased 
bone mineral density (Thomas, 1997). 
 
Alcohol can also lead to interference with proper 
nutrition, especially calcium and vitamin D 
intake.  Individuals who consume moderate to 
excessive amounts of alcohol often have an 
imbalanced diet with a decreased consumption 
of calcium (Wardlaw & Weese, 1995).  
Additionally, research has revealed that 
alcoholics have a reduced ability to produce 1,25 
dihydroxyvitamin D in the renal tubules 
(Wardlaw & Weese, 1995).  By consuming a 
calcium deficient diet and not having an 
adequate capacity to produce vitamin D, which 
is necessary for calcium absorption, the 
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consumption of alcohol can lead to an inability 
of the bone to reach its maximum strength. 
 
A final way that alcohol can increase one’s risk 
of fractures is due to balance difficulties 
experienced during inebriation which can 
increase the risk for falls.  If a woman with poor 
bone health falls, she is more likely to break a 
bone than a women with good bone health 
(Thomas, 1997).  All in all, alcohol may not 
have a direct influence on bone health, but 
through indirect means, a lifestyle that involves 
alcohol intakes of more than one drink per day 
can increase one’s risk of osteoporosis or 
osteoporotic fracture (Laitinen & Välimäki, 
1993). 
 
Cigarette Smoking 
Smoking puts women at risk for osteoporosis 
because smoking decreases serum estrogen 
(Thomas, 1997). A loss of estrogen leads to a 
decreased osteoblastic action progressing to an 
imbalance between resorption and formation.  
Estrogen also plays a role in the absorption of 
calcium, an essential nutrient in the formation of 
strong bones (Wardlaw & Weese, 1995).  
Additionally, smokers tend to have leaner body 
masses perhaps because of the interference of 
smoking with eating (Mazess & Barden, 1991).  
This combination of low estrogen and low body 
weight can lead to an increase in risk for 
osteoporosis.  
 
Smoking is recognized as a risk factor for 
vertebral, forearm, and hip fractures 
(Hollenbach, Barrett-Connor, Edelstein, & 
Holbrook, 1993). Previous research indicates 
that women, who smoke throughout adulthood 
will, by the time of menopause, have an average 
deficit of 5 to 10 percent in bone density 
(Hopper & Seeman, 1994). Additionally this 
same study found that for every 10 pack-years of 
smoking, a 2% decrease in lumbar spine BMD, 
0.9% decrease in femoral neck BMD, and 1.4% 
decrease in femoral shaft BMD were observed. 
Such percentages are sufficient to increase the 
risk of fracture. 
 
As with other diseases associated with smoking, 
cessation can result in some positive effects.  A 
study conducted by Cornuz and colleagues 
(1999) observed that smokers are at an increased 
risk of hip fracture and their risk rises with 
greater cigarette consumption.  However, the 
risk declined among former smokers, but the 
greatest benefit was not observed until 10 years 
after cessation (Cornuz, Feskanich, Willett, & 
Colditz, 1999).  The authors did identify that 
part of the benefit realized was associated with a 
difference in body weight. 
 
The influence of both alcohol and smoking on 
bone health is complex.  In reviewing studies 
regarding these lifestyle factors, it is important 
to realize the multiple potential confounding 
variables: age, heredity, consumption amounts, 
dietary intake, physical activity, etc.  Although it 
is unlikely we will see a heavy smoker 
participating in the recommended levels of 
physical activity for general health, one cannot 
ignore the confounders present when reviewing 
the impact of smoking and alcohol intake on 
bone density. 
 
Heredity and Osteoporosis 
Osteoporosis is a multifaceted disease.  One of 
the potential risk factors associated with disease 
development is family history. Lindsay and 
Dempster (1985) state that 75% of osteoporosis 
cases have a family history component. 
However, the degree to which this is due to 
genetics or to environment is debatable 
(Wardlaw, 1988).  The most commonly cited 
studies supporting a genetic component are twin 
studies.  These studies have estimated the 
heritability of bone density of the lumbar spine 
to be as high as 92% in premenopausal women 
(Pocock, Eisman, Hopper, Yeates, Sambrook, & 
Elberl, 1987) and around 70% for the femoral 
neck (Slemenda, Hui, Longcope, Wellman, 
Johnston, 1990).   Additionally, other twin 
studies have shown a genetic effect but after the 
age of 25, the effect was no longer significant 
(Dequeker, Nijs, Verstraeten, Geusens, & 
Gevers, 1987).  This might suggest that other 
factors such as the environment play a role after 
a certain age.  
 
Research indicates that women who have a 
family history of osteoporosis generally have 
lower bone densities putting them at greater risk 
for osteoporosis in the future (Evans, Marel, 
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Lancaster, Kos, Evans, Wong, 1988; Ulrich, 
Georgiou, Snow-Harter, & Gillis, 1996; 
Francois, Benmaler, Guaydier-Souquieres, 
Sabatier, & Marcelli, 1999; Diaz, O’Neill, & 
Silman, 1997).  Several studies have been 
conducted on mother-daughter pairs to identify 
familial similarities in osteoporosis risk.  A 
study by McKay and colleagues (1994) observed 
positive mother-daughter correlations ranging 
from 0.57 (p<0.05) for the proximal femur to 
0.38 (NS) for the third lumbar vertebrae. 
Additionally, a study done by Krall & Dawson-
Hughes (1993) observed estimates of heritability 
at peripheral sites such as the radium and os 
calcis.  These studies indicate that women who 
have a family history of osteoporosis should be 
encouraged to have bone density scans and to 
participate in preventive behaviors. 
 
Although women with a family history of 
osteoporosis should be advised to care for 
themselves and to practice osteoporosis 
prevention behaviors, women without a family 
history should not consider themselves safe.  
Measures of family resemblance often do not 
clearly differentiate the relative contributions of 
shared environmental factors and genetic factors 
(Tudor-Locke & McColl, 2000).  Genetic 
interactions may be as complex as inadequate 
vitamin D receptors to as simple as children 
emulating their parents’ cooking and exercise 
behaviors.  Additionally, in trying to assess 
one’s risk of osteoporosis, simply considering 
the maternal side of the family tree may not be 
adequate. 
 
An offspring is a combination of genes from two 
parents and a combination of behaviors from 
two parents.  As a result, a person may be 
susceptible to the development of osteoporosis 
independent of family history.  Consequently, 
every woman should be aware of her familial 
history related to osteoporosis, but she should 
also assume personal responsibility in her 
prevention of developing this disease. 
 
Ethnicity and Osteoporosis 
The incidence of hip fracture and osteoporosis 
varies widely among ethnic groups.  The highest 
rates have been reported among whites of 
northern European ancestry (Luckey, 
Wallenstein, Lapinski, & Meier, 1996). 
Research indicates that women of Asian descent 
are also more likely to develop osteoporosis yet 
are less likely to experience osteoporotic hip 
fracture (Hirota, Nara, Ohguri, Manago, Hirota, 
1992; Mackelvie, McKay, Khan, & Crocker, 
2001).  Studies report differences in body size, 
diet, and physical activity between Caucasian 
and Asian girls (Mackelvie et al, 2001).  
Typically, Asian girls consume about 480mg of 
calcium per day and participate in far fewer 
weight bearing activities than Caucasian girls.  
However, Asian girls also consume more plant 
based foods and plant sources of protein which 
may serve as a protective factor (Mackelvie et 
al., 2001). 
 
Other studies have substantiated the reduced risk 
of hip fracture among Asian women as 
compared to Western Caucasian women.  Life- 
and work-style differences between these 
cultures (i.e. sleeping on hard floors vs. beds, 
sitting on hard floors vs. couches, walking vs. 
driving) may be responsible for part of this 
reduced risk (Fujita, 1994).  This is further 
supported with the increase in hip fractures 
among native Japanese women with the 
progressive Westernization of the Japanese 
lifestyle (Fujita, 1994). 
Although Asian women seem to have less risk 
for osteoporotic hip fracture, it may not be due 
to the adherence to osteoporosis prevention 
behaviors.  Studies have shown that Asian 
women have similar osteoporosis risk factors as 
Caucasian women, such as low calcium intake 
and lack of physical activity (Lau, 
Suriwongpaisal, Lee, De, Festin, Saw, et al., 
2001).  Additional risk factors found to be 
influential in the development of osteoporosis 
among Asian women were the low intake of 
dairy product in childhood (due to lactose 
intolerance), frequency of dieting, and skipping 
meals; all similar to those of Caucasian women 
(Hirota et al., 1992).  However, the lack of 
osteoporotic hip fractures may be due to a lower 
center of gravity due to the shorter posture 
shared by many Asian women (Tudor-Locke & 
McColl, 2000). 
 
Compared to those of African American or 
Hispanic ethnicities, White (non-Hispanic) and 
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Asian women are at greater risk for osteoporosis 
(Pun, Chan, Chung, & Wong, 1990).  However, 
the mechanism for this difference is not known. 
Some research indicates that African American 
and Hispanic women achieve a higher peak bone 
density and lose bone density after menopause at 
a slower rate (Luckey et al., 1996).  
 
Although research indicates that certain 
ethnicities are at a greater risk for osteoporosis 
than others, adherence to known osteoporosis 
prevention behaviors should be practiced.  
Ethnicity is not merely one’s skin color.  
Ethnicity involves traditions, practices, and 
environmental influences (Tudor-Locke & 
McColl, 2000).  Overall, osteoporosis is a 
multifaceted disease in which ethnicity is just a 
small fraction of the puzzle. 
 
Medical History and Osteoporosis 
As research in the area of osteoporosis continues 
to expand, new factors for concern are revealed.  
Within one’s medical history, various 
medications have been demonstrated as 
protective or risk factors.  Additionally, medical 
conditions such as eating disorders have also 
been shown to be potential risk factors for 
osteoporosis development. 
 
Medications and Their Effects on 
Osteoporosis  
Corticosteroids/ Glucocorticoids. The 
association between osteoporosis and 
corticosteroids or glucocorticoids was made 
shortly after the first use of these drugs in 
humans in the 1950s (Eastell, 1995). 
Corticosteroid treatments are so strongly related 
to the development of osteoporosis that they 
negate other factors that may be protective (i.e. 
race) (Lucasey, 2001).  Corticosteroids are used 
for a variety of conditions such as asthma, 
rheumatoid arthritis, lupus, and inflammatory 
bowel disease.  Concern is high among health 
educators because the number of young people 
who report using steroid medications is 
increasing. 
 
Glucocorticoids affect bone in many ways.  
They adversely affect bone formation, bone 
resorption, calcium entry into the body in the gut 
and calcium exit from the body in the renal 
tubule (Reid, 1997).  Osteoblasts are a group of 
bone cells primarily affected by glucocorticoids. 
These compounds affect osteoblasts by 
decreasing their proliferation, matrix synthesis, 
and decreasing their life span.  This effect is 
thought to be mediated in part by a reduction in 
the production of local growth factors such as 
insulin-like growth factor 1 (Manolagas & 
Weinstein, 1999).  When osteoblasts activity is 
hindered or decreased, it stands to reason that 
bone density will be compromised and thereby 
increase one’s risk of fracture. 
 
Research has also revealed that steroid-treated 
patients experience a state of calcium 
malabsorption (Klein, Arnaud, & Gallagher, 
1977; Nordin, Marshal, Francis, & Crilly, 1981).  
Additionally, these patients experience a state of 
hypercalciuria which has been reported to be 
double of that in non-steroid using controls 
(Reid & Ibberston, 1987).  Various therapy 
methods have been proposed to address the 
calcium deficit and imbalance.  Among these 
therapies is calcium supplementation of 2000mg 
per day.  Unfortunately, doses as high as 
2400mg per day have shown to have no 
protective effect against the damage done by 
corticosteroids (Eastell, 1995; Reid, 1997; 
Yosipovitch, Hoon, & Leok, 2001). 
 
In addition to causing bone loss, glucocorticoids 
appear to lead to changes in the architectural 
integrity of bone (Daens, Peretx, de Maertelaer, 
Moris, & Bergmann, 1999).  Since bone loss 
occurs rapidly in the first 6 to 12 months of 
steroid therapy with a 5% to 20% decrease in 
bone density, it has been estimated that between 
30% and 50% of long-term corticosteroid users 
will experience fractures (Lukert & Raiax, 
1990). 
 
Despite all the information about glucocorticoid-
induced osteoporosis, few patients are provided 
with information about side effects and few are 
counseled on how to help prevent secondary 
osteoporosis.  A study in England showed that 
only 6% of patients receiving glucocorticoid 
therapy received calcium supplementation (Peat, 
Healy, Reid, & Ralston, 1995) while another 
study out of England showed that only 14% of 
patients received prophylactic medication 
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(Walsh, Wong, Pringle, & Tattersfield, 1996).  
A further study conducted by Buckley and 
colleagues (1999) found that 58% of 
postmenopausal women received osteoporosis 
preventive treatment while using corticosteroids 
while premenopausal women and men were less 
likely to be treated. 
 
Some researchers have argued that concern 
about steroid use should not be applied 
universally to all corticosteroids.  There has 
been a lot of debate about the risks associated 
with oral glucocorticoids versus inhaled 
corticosteroids.  Most of the data that exists 
correlates secondary osteoporosis and 
corticosteroid use based on the oral mode of 
administration.  However, the few studies that 
have reviewed the effects of inhaled 
corticosteroids have identified osteoporosis risks 
as well.  A study done Marystone and colleagues 
(1995) showed that oral steroid users had 
significant reductions in bone density when 
compared to non-steroid users.  However, 
inhaled steroid users in the study showed 
intermediate reductions in bone mass when 
compared to non-steroid users although these 
values were not significant.  Another study 
performed by Wong and colleagues (2000) 
showed a negative relation between total 
cumulative dose of inhaled corticosteroid and 
bone mineral density in patients with asthma. 
 
Regardless of the route of administration, 
women who are utilizing corticosteroids, for any 
number of medical conditions, should receive 
counseling about ways to prevent secondary 
osteoporosis.  Several behaviors should be 
adhered to and they are consistent with 
recommendations for non-steroid users in the 
prevention of osteoporosis.  Women should 
receive primary prevention at the onset of 
corticosteroid therapy.  This should include 
dietary advice to increase calcium and vitamin D 
while reducing sodium and caffeine intake.  
Women should also be counseled to participate 
in weight-bearing activities and to limit 
cigarettes and alcohol consumption.  
Additionally, women should receive a baseline 
bone density scan and be prescribed medications 
that have demonstrated a bone-protective role in 
the use of corticosteroids such as 
bisphosphanates (Eastell, 1995). 
 
Depot Medroxyprogesterone (DMPA)/(Depo-
Provera). DMPA is a progestin-only 
contraceptive that contains no estrogen.  In 
1992, it was approved by the Federal Drug 
Administration (FDA) and since then has been 
utilized by many women who struggle with 
contraceptive adherence or have a difficult time 
remembering to use contraception (Kass-Wolfe, 
2001).  There are numerous side effects of 
DMPA including menstrual irregularities 
including amenorrhea, weight gain, headaches, 
bloating of the abdomen or breasts, mood 
changes, and reduced libido (Kaunitz, 1998). 
 
Depot medroxyprogesterone acetate (DMPA) is 
an injectable progesterone contraceptive 
technique that is used by over 3.5 million 
women in over 90 countries of the world 
(Cundy, Evans, Roberts, Wattie, Ames, & Reid, 
1991; Mark, 1994).  It works by primarily 
inhibiting ovulation through the suppression of 
follicle-stimulating hormone (FSH) and 
luteinizing hormone (LH) levels and causing a 
decrease in estrogen levels (Kass-Wolff, 2001; 
Mark, 1994).  As a result, ovulation stops and in 
many women, with continued use, they become 
amenorrheic (Cundy, et al., 1991). Since the 
recognition of estrogen deficiency as a cause of 
bone demineralization is widely accepted, there 
is growing concern about the potential 
development of osteoporosis and fractures with 
this contraceptive technique (Mark, 1994).  
 
Contraceptive methods that decrease bone 
density in a population already deficient in 
calcium are a rising concern in women’s health 
(Kass-Wolff, 2001). Studies indicate that women 
who use Depo-Provera, for a year or longer, 
have lower bone densities when compared to 
women who do not use this medication 
(Bahamondes, Perrotti, Castro, Faundes, Petta, 
& Bedone, 1999).  Other studies have supported 
this finding.  A study conducted by Cundy and 
colleagues (1991) demonstrated that users of 
DMPA for 5 or more years had a significant 
reduction in bone density as compared to 
nonusers: lumber spine -7.5% and femoral neck 
-6.6%. 
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The loss of bone density occurs rapidly when 
using Depo-Provera (Cundy & Reid, 1997). In a 
study by Cromer and colleagues (1996), the 
researchers compared subjects who used oral 
contraceptives, Norplant, and DMPA to non-
contraceptive users.  At the end of one year, the 
researchers found that bone density significantly 
decreased by 1.5% in the DMPA users when 
compared to the controls. Additionally, at the 
end of two years a significant bone density 
decrease of 3.1% was observed (Cromer, Blair, 
Mahan, Zibners, & Naumovski, 1996). 
Research indicates that the use of Depo-Provera 
should be approached with caution.  Counseling 
about this contraceptive is vital for women to 
understand the potential detrimental side effects.  
Although the loss of bone mass when using 
DMPA is considered to be temporary (Cromer et 
al., 1996) and reversible after treatment is 
discontinued, it is important to realize that the 
window of bone mass accrual is small and 
should be maximized. As a result, if bone 
density is decreased for 2-3 years due to DMPA 
use, these women are potentially at risk for 
achieving a lower peak bone mass due to this 
setback and therefore are at a greater risk of 
osteoporosis and fracture. 
 
Oral contraceptives.  Many young women 
choose oral contraceptives for various reasons 
other than their primary purpose of 
contraception.  Oral contraceptives may be 
chosen to reduce menstrual cramps, regulate 
menstrual cycles, or as partial treatment for 
endometriosis.  Research related to the effect of 
oral contraceptives as a means of osteoporosis 
prevention is inconclusive.  
 
Several research studies have been conducted 
that show positive relationships between oral 
contraceptive use and the prevention of bone 
loss.  These studies have been conducted on 
women at various ages and at various life stages.  
One of the most referred to studies was 
conducted by Kleerekoper and colleagues 
(1991).  This cross-sectional, retrospective study 
of over 2200 women found that women with a 
history of oral contraceptive use were 
significantly more likely to have high bone 
mineral density measurements than those who 
did not have a history of oral contraceptive use 
(Kleerekoper, Brienza, Schultz, & Johnson, 
1991).  Additionally, a significant increase in 
bone mineral density was found with greater 
than 10 years of oral contraceptive use.  The 
limitations of this study was that is did not 
control for smoking or exercise (Kleerekoper et 
al., 1991). 
 
A study conducted by Lindsay, Tohme, and 
Kanders (1986) compared the bone density at 
various stages of life in women who ever used 
oral contraceptives versus those who never used 
oral contraceptives (OCs).  An increase in bone 
mass of about 1% per year was observed among 
premenopausal women who had used OCs 
versus nonusers while there was no difference 
observed between matched-controls in the 
postmenopausal group (Linsay et al., 1986).  
 
While many research projects indicate that oral 
contraceptives have an independent positive 
effect on bone density (Cooper, Hannaford, 
Croft, & Kay, 1993; Recker et al., 1992; Van 
Winter & Bernard, 1998), other research 
indicates no effect on bone density.  In a study 
by Mazess and Barden (1991) the effect of oral 
contraceptive (OC) use on bone density was 
evaluated in 300 women between the ages of 20 
and 39.  The authors controlled for calcium 
intake, exercise, and smoking.  No association 
was found between OC use and bone density.   
 
Additional studies have not found a positive 
association between OC use and bone density. A 
study by Collins and colleagues (1988), found 
no significant differences in the lumbar bone 
mineral content, central density, or bone mineral 
density measurements between OC users and 
non-users.  These subjects were matched for age, 
weight, and height.  Furthermore, this study did 
not find a significant difference between the 
groups and the duration of oral contraceptive use 
which was up to 84 months in duration (Collins, 
Thomas, Harding, Cook, Turner, & Collins, 
1988). 
 
The variation in the findings of these studies can 
be related to many factors including study 
design, mode of bone density measurement, oral 
contraception composition, and duration of use.  
Many of the studies that reported positive 
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associations between bone mineral density and 
oral contraception use reviewed women who 
used OCs when they contained 50µg or more of 
estrogen.  Today’s oral contraceptive is 
considered low-dose and contains between 20µg 
and 40µg of estrogen.  As a result, the lower 
dose of estrogen may prevent OCs from having 
positive effects on bone mineral density.  
Although they may not assist by increasing bone 
mineral density, OCs may slow down bone loss 
suppressing bone resorption which is evident in 
lower urinary calcium excretions (Shargil, 
1985). 
 
Research regarding osteoporosis prevention and 
oral contraception use is controversial.  Those 
who may improve their bone density with the 
use of OCs are women who are already 
hypoestrogenic, have irregular menstrual cycles, 
or women who have other conditions that 
interfere with their estrogen producing 
capabilities.  Although some protection may be 
offered for these special populations, women 
should not fall under the misperception that they 
are completely protected from osteoporosis 
development due to their use of OCs. Protecting 
oneself from this multifaceted debilitating 
disease requires attention to multiple prevention 
strategies. 
 
Eating Disorders and Their Effects on 
Osteoporosis  
Disordered eating refers to the spectrum of 
abnormal and harmful eating patterns used in a 
misguided attempt to lose weight or maintain a 
lowered body weight (Beals, Brey, & Gonyou, 
1999).  Because lower bone mineral density is 
one potential physiological consequence of 
eating disorders, the risk for osteoporosis among 
women afflicted with these diseases is greater 
(Clark, 1997).  Both anorexia nervosa and 
bulimia nervosa and their associated behaviors 
increase a woman’s risk for the development of 
osteoporosis. 
 
Anorexia nervosa is a chronic illness that affects 
1% of adolescent females and is characterized 
by a fear of fatness, self-imposed semistarvation 
and weight loss.  Additionally, the illness has a 
high morbidity and is eventually fatal in 10-15% 
of cases (Seeman, Szmukler, Formica, 
Tsalamandris, & Mestrovic, 1992).  Common 
clinical features of anorexia nervosa are estrogen 
deficiency (accompanied by amenorrhea) and a 
significant reduction in body weight (Treasure & 
Serpell, 2001). 
Chronic anorexia nervosa is known to lead to 
osteopenia and osteoporosis in adults (Rigotti, 
Neer, Skates, Herzog, & Nussbaum, 1991; 
Seeman et al., 1992).  Estrogen status is likely to 
be a major cause of osteopenia and osteoporosis 
in patients with anorexia nervosa (Treasure & 
Serpell, 2001).  The occurrence of estrogen 
deficiency during the first three decades of life 
can increase the risk of osteoporosis by 
preventing the attainment of peak bone density 
and by causing accelerated bone loss (Seeman et 
al., 1992). 
 
Other factors that may be related to the 
development of osteoporosis in women with 
anorexia nervosa are nutritional intake and 
physical activity.  Due to the intense fear of 
being fat, many anorexics strictly limit their 
caloric intake.  To limit their caloric intake they 
consume foods that are low calorie which 
oftentimes excludes foods rich in calcium such 
as dairy products (Treasure and Serpell, 2001).  
This extreme dietary limitation often limits their 
intake of other necessary nutritional components 
for bone health such as protein and vitamin D. 
 
Besides severely limiting dietary intake, 
anorexics participate in excessive physical 
activity (Seeman et al., 1992).  Although weight-
bearing exercise can help protect against 
osteoporosis, excessive exercising can be 
associated with leanness and amenorrhea.  
Studies have been conducted to evaluate the 
effect of amenorrhea in young women suffering 
from anorexia nervosa.  A study by Davies, Hall, 
and Jacobs, (1990) showed that the mean bone 
density was 15% lower for women with 
amenorrhea than age-matched controls and was 
related to the duration of amenorrhea and the 
severity of estrogen deficiency.  This loss in 
bone density is not regained upon recovery from 
anorexia nervosa.  A study by Hartman and 
colleagues (2000) found that for women who 
had been clinically recovered from anorexia 
nervosa on average of 21 years, their bone 
mineral density did not fully return to normal.  
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This was especially true when reviewing the 
BMD of the femur (Hartman, Crisp, Rooney, 
Rackow, Atkinson, & Patel, 2000). 
 
The risk of osteoporosis occurring in other 
eating disorders has also been investigated.  
Studies reviewing women formally diagnosed 
with bulimia nervosa and other nonspecified 
eating disorders have been found to have 
significantly lower bone mineral densities than 
expected when compared to control data 
(Anderson, Woodward, & Lafrance, 1995).  
These results are not completely surprising 
because between 50%-60% of patients with a 
current diagnosis of bulimia nervosa have a 
previous history of anorexia nervosa (Fairburn 
& Hope, 1988). 
 
While amenorrhea is a diagnostic criterion for 
anorexia, menstrual irregularities occur in only 
about half of patients with bulimia (Seidenfeld 
& Rickert, 2001). Although menstrual 
irregularities may not be enough to increase risk 
of osteoporosis in bulimic patients, the 
compensatory behaviors of self-inducing 
vomiting, abuse of laxatives and diuretics, abuse 
of diet pill, and caloric restriction can all affect 
bone health.  Not consuming adequate calcium 
and other nutritional components necessary for 
bone health may influence the density and 
strength of bones later in life.  However, at this 
time, no studies have identified an increased risk 
of osteoporosis fractures in previous or current 
bulimia nervosa patients (Seidenfeld & Rickert, 
2001). 
 
Summary 
Osteoporosis is a multifaceted disease.  Multiple 
factors have been implicated in the development 
of osteoporosis including dietary factors, 
heredity, ethnicity, lifestyle factors, medication 
use, and eating disorders.  Although some of 
these factors are not alterable, the majority of 
them can be changed. Through the dissemination 
of osteoporosis prevention materials and 
information (see PowerPoint 1), health educators 
and other health professionals will increase 
knowledge about osteoporosis, increase 
osteoporosis prevention behaviors, and reframe 
the attitudes of women and men about their risk 
for developing this debilitating disease. 
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